Bijlenga, Philippe http://orcid.org/0000-0003-0548-9936
,
Morita, Akio
Ko, Nerissa U.
Mocco, J.
Morel, Sandrine
Murayama, Yuichi
Wermer, Marieke J. H.
Brown, Robert D. Jr.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (HHSN271201200034C)
Neurocritical Care Society
St. Jude Medical
Article History
First Online: 10 May 2019
Conflicts of interest
: Dr. Bijlenga and Dr. Morel have received research grants from SystemsX.ch a Swiss initiative for Systems Biology and evaluated by the Swiss National Science Foundation. Dr Morita has nothing to disclose. Dr Brown has nothing to disclose. Dr Mocco reports grants and other from Stryker, grants and other from Penumbra, grants and other from Medtronic, grants and other from Microvention, personal fees and other from Imperative Care, personal fees and other from Cerebrotech, personal fees and other from Viseon, personal fees and other from Endostream, personal fees and other from Rebound Therapeutics, personal fees and other from Vastrax, personal fees and other from Blink TBI, personal fees and other from Serenity, personal fees and other from NTI, personal fees and other from Neurvana, personal fees, and other from Cardinal Consulting, outside the submitted work. Dr Wermer has nothing to disclose. Dr Ko reports grants from National Institutes of Health/NINDS, other from Edge Therapeutics, during the conduct of the study. Dr Murayama reports grants and personal fees from Stryker Neurovascular, grants from Siemens Healthcare, and personal fees from Kaneka Medics, during the conduct of the study.
: This article does not contain any studies with human participants or animals performed by any of the authors.